Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1Phase 2 Interventional

Phase 1/2 Study of S-1 and Cisplatin in Advanced Gastric Cancer

ClinicalTrials.gov ID: NCT00072787

Public ClinicalTrials.gov record NCT00072787. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 26, 2026, 5:24 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase I/II, Open-Label, Nonrandomized, Dose-Finding Safety, Tolerance, Pharmacokinetic, and Efficacy Study of Orally Administered S-1 in Combination With Cisplatin in Patients With Advanced Gastric Cancer

Study identification

NCT ID
NCT00072787
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1, Phase 2
Lead sponsor
Taiho Oncology, Inc.
Industry
Enrollment
41 participants

Conditions and interventions

Conditions

Interventions

  • S-1 Drug
  • cisplatin Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 30, 2003
Primary completion
Feb 28, 2006
Completion
Apr 30, 2006
Last update posted
Sep 2, 2024

2003 – 2006

United States locations

U.S. sites
11
U.S. states
6
U.S. cities
6
Facility City State ZIP Site status
Rosen, Lee Los Angeles California 90025
University of Southern California Norris Comprehensive Cancer Center Los Angeles California 90089
Chong, Clayton Honolulu Hawaii 96817
Straub Clinic and Hospital Honolulu Hawaii 96817
Northwestern University Robert H Lurie Comprehensive Cancer Center Chicago Illinois 60611
University of Chicago Chicago Illinois 60637
Lovelace Sandia Health System Albuquerque New Mexico 87108
New Mexico VA Health Care System Albuquerque New Mexico 87108
University of New Mexico - Albuquerque Albuquerque New Mexico 87131
Abramson Cancer Center at the University of Pennsylvania Philadelphia Pennsylvania 19104
MD Anderson Cancer Center Houston Texas 77030

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00072787, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 2, 2024 · Synced Jun 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00072787 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →